
The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.

The graph describes